NO951650L - Forebyggende middel mot blodplateaggregering - Google Patents

Forebyggende middel mot blodplateaggregering

Info

Publication number
NO951650L
NO951650L NO951650A NO951650A NO951650L NO 951650 L NO951650 L NO 951650L NO 951650 A NO951650 A NO 951650A NO 951650 A NO951650 A NO 951650A NO 951650 L NO951650 L NO 951650L
Authority
NO
Norway
Prior art keywords
platelet aggregation
prevention
ch2ch2ch2
ch2ch2
methyl
Prior art date
Application number
NO951650A
Other languages
English (en)
Other versions
NO951650D0 (no
Inventor
Nobuo Mochizuki
Shuichi Souma
Takayoshi Sasaki
Yukihiro Kanaguchi
Nobuhiro Umeda
Original Assignee
Nippon Soda Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Soda Co filed Critical Nippon Soda Co
Publication of NO951650L publication Critical patent/NO951650L/no
Publication of NO951650D0 publication Critical patent/NO951650D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Forebyggende middel mot blod- plateaggregering, hvilket som aktiv bestanddel omfatter en forbindelse representert ved den følgende generelle formel [I]: hvori Y er -CH2CH2- eller -CH2CH2CH2-, R er hydrogen eller metyl og representerer en enkeltbinding eller en dobbeltbinding, eller et farmasøytisk forenlig kompleks derav.
NO951650A 1992-11-02 1995-04-28 Forebyggende middel mot blodplateaggregering NO951650D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP31773992 1992-11-02
JP4352151A JP2806192B2 (ja) 1992-11-02 1992-12-10 血小板凝集抑制剤
PCT/JP1993/001527 WO1994009784A1 (fr) 1992-11-02 1993-10-22 Inhibiteur d'agregation plaquettaire

Publications (2)

Publication Number Publication Date
NO951650L true NO951650L (no) 1995-04-28
NO951650D0 NO951650D0 (no) 1995-04-28

Family

ID=26569128

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951650A NO951650D0 (no) 1992-11-02 1995-04-28 Forebyggende middel mot blodplateaggregering

Country Status (8)

Country Link
US (1) US5663172A (no)
EP (1) EP0667158A4 (no)
JP (1) JP2806192B2 (no)
KR (2) KR0145196B1 (no)
AU (1) AU674550B2 (no)
CA (1) CA2148078C (no)
NO (1) NO951650D0 (no)
WO (1) WO1994009784A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2806192B2 (ja) * 1992-11-02 1998-09-30 日本曹達株式会社 血小板凝集抑制剤
AU3855995A (en) * 1994-11-11 1996-06-06 Nippon Soda Co., Ltd. Optically active compound
DE19514568A1 (de) 1995-04-20 1996-10-24 Merck Patent Gmbh Arylalkyl-pyridazinone
KR100811865B1 (ko) * 2006-12-08 2008-03-10 주식회사 레고켐 바이오사이언스 인자 Ⅶａ 억제 활성을 갖는 피리미디논 또는 피리다지논유도체
CN110117257B (zh) * 2018-02-05 2022-12-06 安徽省新星药物开发有限责任公司 一种含胍基的p2y12受体拮抗剂、制备方法及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU621087B2 (en) * 1988-02-13 1992-03-05 Nippon Soda Co., Ltd. Pyridazinone derivatives
JP2717687B2 (ja) * 1988-02-13 1998-02-18 日本曹達株式会社 ピリダジノン誘導体及びその製造方法
ES2131506T3 (es) * 1990-09-21 1999-08-01 Rohm & Haas Dihidropiridacinonas y piridacinonas como fungicidas.
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
JPH05140116A (ja) * 1991-11-21 1993-06-08 Nippon Soda Co Ltd 光学活性な化合物
JP2806192B2 (ja) * 1992-11-02 1998-09-30 日本曹達株式会社 血小板凝集抑制剤

Also Published As

Publication number Publication date
WO1994009784A1 (fr) 1994-05-11
AU674550B2 (en) 1997-01-02
CA2148078A1 (en) 1994-05-11
JP2806192B2 (ja) 1998-09-30
AU5286293A (en) 1994-05-24
EP0667158A1 (en) 1995-08-16
US5663172A (en) 1997-09-02
KR950703960A (ko) 1995-11-17
JPH06192098A (ja) 1994-07-12
KR0145196B1 (en) 1998-07-15
EP0667158A4 (en) 1997-12-17
NO951650D0 (no) 1995-04-28
CA2148078C (en) 1998-06-09

Similar Documents

Publication Publication Date Title
DK0650476T3 (da) Perifert, vasodilaterende middel, der indeholder N-acylerede 4-aminopiperidinderivater som aktive bestanddele
HU9500240D0 (en) New prolin-amide derivatives and pharmaceutical compositions containing them as active component
NO952854L (no) 1-arylpyrimidin-derivater
CA2268709A1 (en) Hiv protease inhibitors
CA2183972A1 (en) Oxazolidinone derivatives and pharmaceutical compositions containing them
RU94044436A (ru) Способы подавления атрофии кожи и влагалища
CA2295063A1 (en) Indole compounds as anti-inflammatory/analgesic agents
IL109615A0 (en) Polypeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DK0759919T3 (da) Azolidindioner som antihyperglykæmiske midler
CA2336412A1 (en) Medicament for treatment of diabetes
RU95105435A (ru) N-замещенные производные 3-азабицикло [3.2.0]гептана в качестве нейролептического средства
WO1993014767A3 (en) Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections
CA2365359A1 (en) Medicaments containing a sulfopyranosylglycerol derivative
DK0585722T3 (da) Benzimidazolderivater som antimikrobielt middel mod Campylobacter pylon
KR910004191A (ko) 신질환치료제
NO951650L (no) Forebyggende middel mot blodplateaggregering
EP0754454A4 (en) CHOLINESTERASE ACTIVATOR
CA2248794A1 (en) Medicament for preventive and treatment for viral infectious diseases
DE69414396D1 (de) Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten
NO983217D0 (no) Terapeutiske anti-astmamidler som inneholder selenforbindeler
AU1855088A (en) Treating agent for heart failure
CA2133186A1 (en) 3- or 4-glycosyloxybenzopyran derivative and antiallergic agent containing the derivative as active ingredient
EP0414903A4 (en) New thioproline derivative
AU6101890A (en) Therapeutic agents for the treatment of peptic ulcer disease
EP0862917A4 (en) ANTIFUNGAL COMPOSITION